Solution
Industries
Resources
About
Beacon Search

ASCENSIA DIABETES CARE HOLDINGS AG

Company Snapshot

Founded: 2016
Entity Type: Private
Region: Switzerland
Headquarter: Basel, Switzerland
Key Geographics: Switzerland, U.S.
Corporate Address: Peter Merian-Strasse 90 4052 Basel, Switzerland Tel: +41-61-560-8700 www.ascensia.com

Company Overview

In 2016, when Bayer sold its diabetes care business to KKR/Panasonic Healthcare Holdings Co. Ltd. (PHCHD), Ascensia Diabetes Care was born. Ascensia boasts several products designed to assist people with diabetes in managing their disease and is probably best known for the Contour line of blood glucose monitoring systems. This line includes the Contour Next and Contour Plus BGM systems, disposables, and diabetes management tracking systems, which work on smartphones.

Ascensia Diabetes Care has formed alliances and partnerships with other companies and organizations to advance diabetes care. These alliances are with Medtronic, Voluntis, Insulet, and others. Voluntis works to develop therapeutic software for users of devices such as the Contour BGM systems.

ASCENSIA DIABETES CARE HOLDINGS AG In Reports

Patient Monitoring Devices: Global Markets

Bcc Research Analyst provide a detail report on patient monitoring devices market report includes global revenue ($ Million) for base year data of 2024, estimated year data of 2025, and forecasts through 2030.

Global Markets for Diabetes Therapeutics and Diagnostics

BCC Market Research Report for Diabetes Therapeutics & Diagnostics provides a detailed review including diabetes medications, insulin delivery devices, monitoring devices, and insulin pumps.

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

BCC Research Market Report for Continuous Glucose Monitoring Market. key factors driving the growth of the CGM market covering top player Abbott Laboratories, F.Hoffman-la Roche, LifeScan, Medtronic, Dexcom, and...

View All Reports

ASCENSIA DIABETES CARE HOLDINGS AG In News

Ascensia Launches Global Art Competition Exploring the Link Between Diabetes and Anxiety - Business Wire

Business Wire - Jul 24, 2025

Senseonics reclaims Eversense 365 distribution from Ascensia - BioWorld MedTech

BioWorld MedTech - Sep 17, 2025

Global diabetes care company Ascensia opens research headquarters in Valhalla - Westfair Communications

Westfair Communications - Oct 07, 2025

Blood Glucose Monitoring Devices Market | Global Market Analysis Report - 2035 - Fact.MR

Fact.MR - Nov 17, 2025

Read All News

Company's Business Segments

  • Products : Eversense Continuous Glucose Monitoring System, CONTOUR Blood Glucose Monitoring Systems, Others
  • Services : Diabetes Management Solutions, Others

Applications/End User Industries

  • Pharmaceuticals
  • Digital Health and Technology
  • Medical Devices
  • Diabetes Management
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment